jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Sept. 22, 2022

Dec. 12, 2023

jRCT1030220346

A study of the safety and sustainability of pain therapy with human adipose-derived mesenchymal stem cell cond itioned medium

A study of the safety and sustainability of pain therapy with conditioned medium

Ueda Yasuo

SAWAI Hospital

Funahasi-cho 8, Nara-shi, Nara 630-8258, Japan

+81-742-23-30861

toukatsu-yo@eos.ocn.ne.jp

Ueda Yasuo

SAWAI Hospital

Funahasi-cho 8, Nara-shi, Nara 630-8258, Japan

+81-742-23-30861

toukatsu-yo@eos.ocn.ne.jp

Recruiting

June. 03, 2022

Sept. 26, 2022

Observational

1. Patients with chronic pain
2. Patients who did not have a satisfactory pain relief effect with standard treatment
3. Patients over 18 years old
4. Patients with normal consent ability
5. Patients who can obtain their free will consent in writing
6. Patients whose doctor recognizes the need for treatment

1. Patients with a history or suspicion of malignant tumor or dementia
2. Drug and stimulant users
3. Patients with no pain other than psychogenic pain
4. Patients who do not understand and agree with this treatment
5. Pregnant
6. Patients that the doctor in charge deems inappropriate

18age old over
No limit

Both

Chronic Pain

D059350

Subjective symptoms
1. Effect of pain on daily life
2. Pain intensity (Numerical Rating Scale; NRS)
3. Pain area

SAWAI Hospital
Medical Ai Ethics Committee
4-3-11 Tsukiji, Chuo-ku, Tokyo, Tokyo

+81-90-3149-7743

magk@magk.co.jp
Approval

June. 03, 2022

none

History of Changes

No Publication date
3 Dec. 12, 2023 (this page) Changes
2 Oct. 28, 2022 Detail Changes
1 Sept. 22, 2022 Detail